Vivos (RDGL) Cost of Revenue (2010 - 2025)
Vivos (RDGL) reported Cost of Revenue of $27857.0 for Q4 2025, up 170.98% on a YoY basis from $10280.0 in Q4 2024, and up 89.58% sequentially from $14694.0 in Q3 2025.
Vivos (RDGL) Cost of Revenue (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 11 years of Cost of Revenue data on file, last reported at $27857.0 in Q4 2025.
- For the quarter ending Q4 2025, Cost of Revenue rose 170.98% year-over-year to $27857.0; the trailing twelve-month figure through Dec 2025 stood at $128135.0 (up 313.62% YoY), and the FY2025 full-year result was $128134.0, up 313.62% from the prior year.
- Cost of Revenue advanced to $27857.0 in Q4 2025, from $14694.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $49753.0 in Q2 2025 to a low of $2018.0 in Q2 2022.
- A 5-year average of $13260.5 and a median of $9000.0 in 2023 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue declined 20.38% in 2024 and surged 497.18% in 2025, its largest moves.
- Tracing RDGL's Cost of Revenue over 5 years: stood at $6000.0 in 2021, then jumped by 78.77% to $10726.0 in 2022, then retreated by 16.09% to $9000.0 in 2023, then increased by 14.22% to $10280.0 in 2024, then jumped by 170.98% to $27857.0 in 2025.
- Business Quant data shows RDGL's Cost of Revenue at $27857.0 in Q4 2025, $14694.0 in Q3 2025, and $49753.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | 27,857.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,857.00 |
| Dec 31, 2025 | 27,857.00 |
| Sep 30, 2025 | 14,694.00 |
| Sep 30, 2025 | 14,694.00 |
| Jun 30, 2025 | 49,753.00 |
| Jun 30, 2025 | 49,753.00 |
| Mar 31, 2025 | 35,831.00 |
| Mar 31, 2025 | 35,831.00 |
| Dec 31, 2024 | 10,280.00 |
| Dec 31, 2024 | 10,280.00 |
| Sep 30, 2024 | 3,919.00 |
| Sep 30, 2024 | 3,919.00 |
| Jun 30, 2024 | 10,780.00 |
| Jun 30, 2024 | 10,780.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |